(Q39443158)

12 September 2017

title

Antiviral activity of derivatized dextrans on HIV-1 infection of primary macrophages and blood lymphocytes (English)

1 reference

12 September 2017

0 references

0 references

0 references

3

1 reference

12 September 2017

N Seddiki

1

1 reference

12 September 2017

E Mbemba

2

1 reference

12 September 2017

L Ylisastigui

4

1 reference

12 September 2017

A Benjouad

5

1 reference

12 September 2017

L Saffar

6

1 reference

12 September 2017

J C Gluckman

7

1 reference

12 September 2017

J Jozefonvicz

8

1 reference

12 September 2017

L Gattegno

9

1 reference

12 September 2017

language of work or name

1 reference

1 November 1997

1 reference

Biochimica et Biophysica Acta

12 September 2017

published in

1 reference

12 September 2017

volume

1362

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

47-55

1 reference

Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Chemokine receptors: gateways to inflammation and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Structure of the antithrombin-binding site in heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Interactions of HIV-1 envelope glycoproteins with derivatized dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

In vitro stimulation of human endothelial cells by derivatized dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Membrane glycolipids and human immunodeficiency virus infection of primary macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

The role of calcium and N-linked glycans in the oligomerization and carbohydrate binding properties of human immunodeficiency virus external envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

HIV-1 subtype and second-receptor use

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Differential antiviral activity of derivatized dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Enzymatic degradation and immunogenic properties of derivatized dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

Effect of substituted dextran derivative on complement activation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900057-4

7 January 2021

10.1016/S0925-4439(97)00057-4

Identifiers

DOI

1 reference

12 September 2017

1 reference